An interview with Dr. Pauline Funchain from Cleveland Clinic in Cleveland, OH, author on "Systemic Therapy for Melanoma: ASCO Guideline Rapid Recommendation Update." Dr. Funchain reviews recent ...
For more than 20 years, hormone therapy for menopause has carried a warning label from the Food and Drug Administration ...
The FDA put a black box warning on estrogen products for hormone therapy in 2003, and it’s stayed there ever since. And women ...
Effective therapy is about more than insight or advice. It is about transformation—a felt shift in how we relate to ourselves and others in real time. Systemic therapy, grounded in family systems ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window While surgical ...
An interview with Dr. John D. Gordan from the University of California, San Francisco, and Dr. Michal G. Rose from Yale Cancer Center and VA Connecticut Healthcare System on "Systemic Therapy for ...
All menopause treatments containing the hormone estrogen are mandated by the US Food and Drug Administration to carry a black box warning on the label, stating that the treatments could increase the ...
While lobectomy is the surgical gold standard for early-stage NSCLC, some patients will continue to need pneumonectomy to achieve radical resection. Historically, the use of adjuvant and neoadjuvant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback